secwatch.observer — SEC 8-K summary
======================================

Issuer:     SBC Medical Group Holdings Inc (SBC)
CIK:        0001930313
Form:       8-K
Filed at:   2024-11-13T23:59:59+00:00
Accession:  0001493152-24-045152
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SBC Medical Q3 revenue $53M (+12% YoY); net income falls to $2M from $8M
------------------------------------------------------------------------

- Q3 revenue $53M (+12% YoY); operating income $13M (-31% YoY, hit by $12.8M stock-based comp).
- Q3 net income attributable to SBC was $2M vs $8M in Q3 2023; nine-month net income $40M (+60%).
- Nine-month revenue $160M (+23%), EBITDA $68M (+21%), EBITDA margin 42%.
- Partner clinics reached 224 as of Sep 30, 2024, up 24 from a year ago.
- Stock-based compensation of $12.8M in Q3 related to listing process reduced operating income.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1930313/000149315224045152/0001493152-24-045152-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1930313/000149315224045152/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-045152

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer